Progressive Collective-exercise Program on the Knee Osteoarthritis

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01850862

Enrollment

Registered

2013-05-10

Start date

2011-06-30

Completion date

2011-11-30

Last updated

2013-05-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Brief summary

The investigators hypothesized that an eight-week collective group exercise program would improve pain, quality of life and functional capacity in patients with knee osteoarthritis (KOA) compared with those receiving no exercise intervention.

Interventions

OTHERCollective group exercise program in patients with KOA

OTHEROrientation (without exercise)

Orientation about osteoarthritis disease but without any exercise program

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

50 Years to 80 Years

Healthy volunteers

Inclusion criteria

* symptomatic and moderate to severe medical diagnostic of KOA. * Subjects with normal cognitive functions and no restriction to perform physical activities were recruited from the hospital's KOA database and eligible to participate if they had presented: Lequesne questionnaire criteria (5 - 13.5), knee pain score between 3 and 7 (on a 0 -10 Visual Analogue Scale), stable doses of non-steroidal anti-inflammatory drugs (NSAIDs) and no regular physical exercise or use of canes in the months prior to the study.

Exclusion criteria

* Symptomatic heart disease; symptomatic disease of the lower limbs (other than KOA); symptomatic lung disease; severe systemic disease; severe psychiatric illness; regular physical exercise (three or more times per week for at least 3 months); drug injection in the knee in the previous 3 months; physiotherapy on the lower limbs in the previous 3 months and absence in two consecutive training sessions or three nonconsecutive sessions

Design outcomes

Primary

Measure	Time frame	Description
Pain	Eight weeks	pain assessed by Visual Analogue Scale

Secondary

Measure	Time frame	Description
quality of life	Eight weeks	quality of life assessed by SF-36 questionnaire

Other

Measure	Time frame	Description
functional capacity	Eight weeks	functional capacity assessed by Lequesne questionnaire and functional tests.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 5, 2026